Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease (Q3325996): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease, translated_summary) |
(Changed label, description and/or aliases in en: translated_label) |
||
label / en | label / en | ||
Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease |
Revision as of 02:42, 25 October 2021
Project Q3325996 in Germany
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease |
Project Q3325996 in Germany |
Statements
70,535.36 Euro
0 references
88,169.2 Euro
0 references
80.0 percent
0 references
2 October 2016
0 references
31 October 2019
0 references
Technische UniversitätDresden
0 references
Entwicklung eines PET-Radiopharmakons für die nuklearmedizinische Bildgebung der Parkinson-Krankheit (German)
0 references
Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease (English)
25 October 2021
0 references
Dresden, Stadt
0 references
Identifiers
672 / 101002267521
0 references